Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Eur J Cancer
; 156: 12-23, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34392187
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein Kinase Inhibitors
/
Crizotinib
/
Anaplastic Lymphoma Kinase
/
Neoplasms, Muscle Tissue
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Eur J Cancer
Year:
2021
Document type:
Article
Country of publication:
Reino Unido